• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项评估间皮素在不明原因胸腔积液中作用的前瞻性试验。

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions.

机构信息

North Bristol Lung Centre, Southmead Hospital, Bristol, UK.

出版信息

Eur Respir J. 2013 Jan;41(1):18-24. doi: 10.1183/09031936.00148211. Epub 2012 Jul 12.

DOI:10.1183/09031936.00148211
PMID:22790919
Abstract

Mesothelin has been proposed as a useful tool in the diagnosis of malignant pleural mesothelioma (MPM). We aimed to examine its diagnostic utility and the impact of renal impairment on results. We prospectively recruited 230 patients with new undiagnosed pleural effusions, testing serum (n=216) and pleural fluid (n=206) mesothelin (by ELISA) during the initial consultation. 28 (12%) out of 230 patients had MPM. Serum mesothelin gave sensitivity 59.3%, specificity 64.7%, negative predictive value (NPV) 91.2%, positive predictive value (PPV) 20.5%, and pleural fluid sensitivity 72.0%, specificity 87.5%, NPV 95.5%, PPV 46.2% for distinguishing effusions due to MPM. In a matched comparison, diagnostic characteristics of pleural fluid mesothelin were superior to serum (p=0.0001). Serum mesothelin levels in patients without MPM were higher in patients with renal impairment (p=0.007) while pleural fluid levels were unaffected. 19 (54%) out of 35 patients with a benign pleural effusion and an estimated glomerular filtration rate ≤ 59 mL · min(-1) had a false-positive serum mesothelin result. The diagnostic accuracy of pleural fluid mesothelin is superior to that of serum and is unaffected by renal function. In patients with a low pre-test probability of mesothelioma, a negative mesothelin test could be reassuring, because of its high NPV. Routine use of mesothelin testing in undiagnosed pleural effusions at presentation appears to be unhelpful.

摘要

间皮素已被提议作为诊断恶性胸膜间皮瘤(MPM)的有用工具。我们旨在检查其诊断效用以及肾功能损害对结果的影响。我们前瞻性招募了 230 名新诊断的胸腔积液患者,在初次就诊时检测血清(n=216)和胸腔积液(n=206)间皮素(通过 ELISA)。230 名患者中有 28 名(12%)患有 MPM。血清间皮素的敏感性为 59.3%,特异性为 64.7%,阴性预测值(NPV)为 91.2%,阳性预测值(PPV)为 20.5%,胸腔积液的敏感性为 72.0%,特异性为 87.5%,NPV 为 95.5%,PPV 为 46.2%,用于区分 MPM 引起的胸腔积液。在匹配比较中,胸腔积液间皮素的诊断特征优于血清(p=0.0001)。无 MPM 的患者中,血清间皮素水平在肾功能不全患者中更高(p=0.007),而胸腔积液水平不受影响。35 名良性胸腔积液且估算肾小球滤过率≤59 mL·min(-1)的患者中,有 19 名(54%)血清间皮素检测结果为假阳性。胸腔积液间皮素的诊断准确性优于血清,且不受肾功能影响。在间皮瘤的低术前概率患者中,由于其高 NPV,阴性间皮素检测可能令人放心。在初次出现未确诊的胸腔积液时,常规进行间皮素检测似乎没有帮助。

相似文献

1
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions.一项评估间皮素在不明原因胸腔积液中作用的前瞻性试验。
Eur Respir J. 2013 Jan;41(1):18-24. doi: 10.1183/09031936.00148211. Epub 2012 Jul 12.
2
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.间皮瘤血清和胸腔积液中可溶性间皮素相关肽水平升高。
Ann Thorac Surg. 2008 Jan;85(1):265-72; discussion 272. doi: 10.1016/j.athoracsur.2007.07.042.
3
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.未确诊胸腔积液中胸水间皮素的临床影响及可靠性
Am J Respir Crit Care Med. 2009 Sep 1;180(5):437-44. doi: 10.1164/rccm.200811-1729OC. Epub 2009 Mar 19.
4
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.在恶性间皮瘤中,血清间皮素比透明质酸具有更高的诊断效用。
Clin Biochem. 2009 Jul;42(10-11):1046-50. doi: 10.1016/j.clinbiochem.2009.03.007. Epub 2009 Mar 18.
5
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.积液中的可溶性间皮素:诊断恶性间皮瘤的有用工具。
Thorax. 2007 Jul;62(7):569-76. doi: 10.1136/thx.2006.068114. Epub 2007 Mar 13.
6
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.骨桥蛋白和血清间皮素在恶性胸膜间皮瘤诊断及预后评估中的应用价值。
Clin Cancer Res. 2007 May 15;13(10):2928-35. doi: 10.1158/1078-0432.CCR-06-2144.
7
Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.恶性胸膜间皮瘤胸腔积液间皮素的临床意义。
Clin Chem Lab Med. 2011 Oct;49(10):1721-6. doi: 10.1515/CCLM.2011.242. Epub 2011 Jun 22.
8
Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.可溶性间皮素相关肽作为恶性胸膜间皮瘤胸腔积液诊断标志物的评估:对细胞学的贡献。
Cancer Invest. 2013 Jan;31(1):43-50. doi: 10.3109/07357907.2012.749265. Epub 2012 Dec 18.
9
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.胸水间皮素作为胸膜恶性间皮瘤诊断的辅助手段。
Dis Markers. 2014;2014:413946. doi: 10.1155/2014/413946. Epub 2014 Nov 23.
10
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.胸腔积液无细胞游离 DNA 完整性指数鉴别包括间皮瘤在内的细胞学阴性恶性胸腔积液。
BMC Cancer. 2012 Sep 25;12:428. doi: 10.1186/1471-2407-12-428.

引用本文的文献

1
Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤预后生物标志物的系统评价、荟萃分析和生物信息学分析
Diagnostics (Basel). 2022 Sep 12;12(9):2210. doi: 10.3390/diagnostics12092210.
2
Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis.采用基于质谱的多重靶向蛋白质组学技术定量检测中高丰度的癌症、感染/炎症和结核病标志物,以诊断胸腔积液。
Sci Rep. 2022 Feb 23;12(1):3054. doi: 10.1038/s41598-022-06924-y.
3
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis.
诊断生物标志物在恶性胸膜间皮瘤中的临床应用:系统评价和荟萃分析。
Eur Respir Rev. 2021 Nov 17;30(162). doi: 10.1183/16000617.0057-2021. Print 2021 Dec 31.
4
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的辅助诊断检查
Cancers (Basel). 2021 Jun 30;13(13):3291. doi: 10.3390/cancers13133291.
5
Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.呼气分析在恶性胸膜间皮瘤诊断中的应用:系统评价。
Int J Environ Res Public Health. 2020 Feb 10;17(3):1110. doi: 10.3390/ijerph17031110.
6
Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.可溶性间皮素相关肽在胸腔积液中对恶性胸膜间皮瘤的诊断价值:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Apr;98(14):e14979. doi: 10.1097/MD.0000000000014979.
7
Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.用于诊断恶性胸膜间皮瘤的胸腔积液生物标志物及计算机断层扫描结果:一项单中心回顾性研究
PLoS One. 2017 Oct 2;12(10):e0185850. doi: 10.1371/journal.pone.0185850. eCollection 2017.
8
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.恶性胸膜间皮瘤和间皮增生:一种用于鉴别诊断的新分子工具。
Oncotarget. 2017 Jan 10;8(2):2758-2770. doi: 10.18632/oncotarget.13174.
9
Brain metastases in malignant pleural mesothelioma.恶性胸膜间皮瘤的脑转移
Clin Exp Metastasis. 2016 Mar;33(3):231-7. doi: 10.1007/s10585-015-9772-8. Epub 2015 Nov 30.
10
The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication.西南地区间皮瘤与培美曲塞试验:一项多中心前瞻性观察性研究,评估化疗反应和预后的新标志物。
Br J Cancer. 2015 Mar 31;112(7):1175-82. doi: 10.1038/bjc.2015.62.